Singapore markets close in 3 hours 41 minutes

Nexien BioPharma, Inc. (NXEN)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.02750.0000 (0.00%)
At close: 10:51AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
0
-
-
-
0
63.858
Selling general and administrative
157.264
282.608
453.728
1,844
2,637
-
Total operating expenses
157.264
282.608
453.728
1,844
2,637
-
Operating income or loss
-157.264
-282.608
-453.728
-1,844
-2,637
-
Interest expense
88.918
79.294
62.365
16.175
0.033
-
Total other income/expenses net
-35
-
-110.264
-
-35
-367.915
Income before tax
-246.182
-361.902
-626.357
-1,860
-2,672
-
Income from continuing operations
-246.182
-361.902
-626.357
-1,860
-2,672
-
Net income
-246.182
-361.902
-626.357
-1,860
-2,672
-
Net income available to common shareholders
-246.182
-361.902
-626.357
-1,860
-2,672
-
Basic EPS
-0.01
-0.01
-0.01
-0.03
-0.05
-
Diluted EPS
-0.01
-0.01
-0.01
-0.03
-0.05
-
Basic average shares
63,208
62,333
57,860
55,400
53,913
-
Diluted average shares
63,208
62,333
57,860
55,400
53,913
-